Seed VC · Basel, Switzerland
MTIP is a Swiss-based growth equity firm specializing in investments in digital health and healthtech companies. Founded in 2014 and headquartered in Basel, MTIP focuses on supporting innovative healthcare technology businesses across Europe, aiming to improve patient outcomes and healthcare efficiency. The firm is recognized for its hands-on approach and sector expertise, partnering with entrepreneurs to scale impactful solutions. MTIP has built a strong reputation within the European venture capital landscape, with a portfolio that includes several high-growth digital health companies.
Business models
saas_b2b, platform
Customer segments
Enterprise, Healthcare Providers, Pharmaceutical Companies, Biotech Companies
Geography
Europe
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
MTIP writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks MTIP alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Family Office
Agic Capital
advanced industrial technology, healthcare technology, medical devices
Family Office
CKM Group
healthcare, diagnostics, preventive medicine
Seed VC
Cordis Asset Management
medical devices, healthcare technology, cardiology
Seed VC
Dieter Von Holtzbrinck Ventures
deep tech, education, digital health
Seed VC
Digital Health Ventures / DHV Management GmbH
digital health, chronic disease management, fertility
Family Office
Evli Growth Partners
insurtech, digital health, SaaS
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. MTIP is one of them — and we'll tell you exactly where they sit in your top 100.